574 related articles for article (PubMed ID: 33681617)
1. 1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors.
Ivanova L; Rausalu K; Žusinaite E; Tammiku-Taul J; Merits A; Karelson M
ACS Omega; 2021 Mar; 6(8):5786-5794. PubMed ID: 33681617
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
[TBL] [Abstract][Full Text] [Related]
3. Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation.
Ivanova L; Rausalu K; Ošeka M; Kananovich DG; Žusinaite E; Tammiku-Taul J; Lopp M; Merits A; Karelson M
ACS Omega; 2021 Apr; 6(16):10884-10896. PubMed ID: 34056242
[TBL] [Abstract][Full Text] [Related]
4. Design and Validation of Novel Chikungunya Virus Protease Inhibitors.
Das PK; Puusepp L; Varghese FS; Utt A; Ahola T; Kananovich DG; Lopp M; Merits A; Karelson M
Antimicrob Agents Chemother; 2016 Dec; 60(12):7382-7395. PubMed ID: 27736770
[TBL] [Abstract][Full Text] [Related]
5. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
Akhrymuk I; Lukash T; Frolov I; Frolova EI
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
[TBL] [Abstract][Full Text] [Related]
6. Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease.
Dhindwal S; Kesari P; Singh H; Kumar P; Tomar S
J Biomol Struct Dyn; 2017 Dec; 35(16):3522-3539. PubMed ID: 27844505
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach.
Merten EM; Sears JD; Leisner TM; Hardy PB; Ghoshal A; Hossain MA; Asressu KH; Brown PJ; Stashko MA; Herring L; Mordant AL; Webb TS; Mills CA; Barker NK; Streblow ZJ; Perveen S; Arrowsmith C; Arnold JJ; Cameron CE; Streblow DN; Moorman NJ; Heise M; Willson TM; Popov K; Pearce KH
bioRxiv; 2024 May; ():. PubMed ID: 38562906
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site.
Narwal M; Singh H; Pratap S; Malik A; Kuhn RJ; Kumar P; Tomar S
Int J Biol Macromol; 2018 Sep; 116():451-462. PubMed ID: 29730006
[TBL] [Abstract][Full Text] [Related]
9. Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease.
Singh KhD; Kirubakaran P; Nagarajan S; Sakkiah S; Muthusamy K; Velmurgan D; Jeyakanthan J
J Mol Model; 2012 Jan; 18(1):39-51. PubMed ID: 21445710
[TBL] [Abstract][Full Text] [Related]
10. The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1.
Göertz GP; McNally KL; Robertson SJ; Best SM; Pijlman GP; Fros JJ
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925658
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into the inhibition of the nsP2 protease from Chikungunya virus by molecular modeling approaches.
Rabelo VW; de Palmer Paixão ICN; Abreu PA
J Mol Model; 2022 Sep; 28(10):311. PubMed ID: 36097090
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors.
El-labbad EM; Ismail MA; Abou Ei Ella DA; Ahmed M; Wang F; Barakat KH; Abouzid KA
Chem Biol Drug Des; 2015 Dec; 86(6):1518-27. PubMed ID: 26212366
[TBL] [Abstract][Full Text] [Related]
13. Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease.
Singh H; Mudgal R; Narwal M; Kaur R; Singh VA; Malik A; Chaudhary M; Tomar S
Biochimie; 2018 Jun; 149():51-61. PubMed ID: 29635044
[TBL] [Abstract][Full Text] [Related]
14. Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2.
Utt A; Das PK; Varjak M; Lulla V; Lulla A; Merits A
J Virol; 2015 Mar; 89(6):3145-62. PubMed ID: 25552719
[TBL] [Abstract][Full Text] [Related]
15. Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches.
Nguyen PT; Yu H; Keller PA
J Mol Graph Model; 2015 Apr; 57():1-8. PubMed ID: 25622129
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-Conjugating Enzyme E2 L3 is Downregulated by the Chikungunya Virus nsP2 Protease.
Ramphan S; Khongwichit S; Saisawang C; Kovanich D; Ketterman AJ; Ubol S; Auewarakul P; Roytrakul S; Smith DR; Kuadkitkan A
Proteomics Clin Appl; 2018 Jul; 12(4):e1700020. PubMed ID: 28975709
[TBL] [Abstract][Full Text] [Related]
17. Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease's active site cysteine residue.
Rausalu K; Utt A; Quirin T; Varghese FS; Žusinaite E; Das PK; Ahola T; Merits A
Sci Rep; 2016 Nov; 6():37124. PubMed ID: 27845418
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Chikungunya virus early replication by intracellular nanoantibodies targeting nsP2 Epitope Rich Region.
Deng Q; Guo Z; Hu H; Li Q; Zhang Y; Wang J; Liao C; Guo C; Li X; Chen Z; Lu J
Antiviral Res; 2022 Dec; 208():105446. PubMed ID: 36270543
[TBL] [Abstract][Full Text] [Related]
19. Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors.
Kumar P; Kumar D; Giri R
Pathogens; 2019 Aug; 8(3):. PubMed ID: 31443266
[TBL] [Abstract][Full Text] [Related]
20. Molecular Modeling and Docking Study to Elucidate Novel Chikungunya Virus nsP2 Protease Inhibitors.
Agarwal T; Asthana S; Bissoyi A
Indian J Pharm Sci; 2015; 77(4):453-60. PubMed ID: 26664062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
